Biotech

All Articles

Enanta's RSV antiviral crushes viral bunch in difficulty research

.Enanta Pharmaceuticals has connected its own respiratory syncytial infection (RSV) antiviral to not...

Biogen containers SAGE-324 partnership after vital trembling fall short

.Biogen has carried out the final rites to its partnership along with Sage Rehabs on SAGE-324, break...

AbbVie Parkinson's medication from $8.7 B Cerevel purchase scores

.On the same day that some Parkinson's ailment medicines are actually being actually cast doubt on, ...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund coming from Bain Financing Lifestyle Sciences, Arch Venture Partn...

Orion to use Aitia's 'electronic doubles' to find new cancer cells medicines

.Finnish biotech Orion has actually snooped possible in Aitia's "electronic double" tech to establis...

Windtree's surprise med rears high blood pressure in most recent period 2 succeed

.While Windtree Rehabs has struggled to develop the economic roots needed to make it through, a peri...

2 cancer biotechs merge, producing worldwide footprint

.OncoC4 is actually taking AcroImmune-- and also its internal medical production abilities-- under i...

Amgen records very first phase 3 gain for $400M eczema medication

.Amgen has shared (PDF) the initial phase 3 records on its $400 million chronic eczema drug, connect...

Biogen, UCB document stage 3 lupus win after stopping working earlier test

.Biogen and also UCB's depend advancing into phase 3 on the back of a broken study aims to have actu...

Aptadir really hopes brand-new RNA inhibitors may reverse tricky cancers cells

.Italian biotech Aptadir Rehabs has actually launched with the guarantee that its own pipeline of pr...